Ascension St. Vincent’s Riverside to offer breakthrough treatments for COPD/emphysema
St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...
Hosted on MSN12d
Boehringer seeks approval of lung disease drug after second Phase III success
Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...
Seeking Alpha18d
Aurion Biotech Pursues IPO For Cornea Disease Treatments
The firm is commercializing and developing treatments for various diseases of the cornea. Its potential market size is rather small, but the company has little apparent direct competition and has ...
Indiatimes19d
Rethinking lung cancer: Risks, early detection, and modern treatment options
Comprehensive approaches including large-scale screening and targeted treatments are essential to reduce lung cancer mortality.
Investing23d
Molgramostim shows promise in rare lung disease treatment
reduce disease burden, and decrease the need for whole lung lavage (WLL), a current treatment for aPAP. According to InvestingPro data, the company maintains a strong financial position with more cash ...
The American Journal of Managed Care26d
Emerging Therapies Shine Hope on Small Cell Lung Cancer Treatment
Novel therapies targeting molecular pathways, including DLL3 and PARP inhibitors, show promise in improving SCLC survival outcomes. Tarlatamab, a DLL3-targeting bispecific T-cell engager, achieved ...
ABC News27d
Heart disease remains leading cause of death in US, new report finds
In 2022, more than 941,600 Americans died from cardiovascular disease. Heart disease remains the leading cause of death in the United States, according to a new report. The American Heart ...